Reaching Consensus on the Definition of Difficult Cholecystectomy
NCT ID: NCT05121181
Last Updated: 2021-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2020-07-01
2021-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods A Delphi study was conducted. Based on the literature, a history of biliary pathology, preoperative clinical, analytical, and radiological data, and intraoperative findings were selected and rated on a Likert scale.
Inter-rater agreement was defined as "unanimous" when 100% of the participants gave an item the same the Likert scale rating; as "consensus" when ≥80% agreed; as "majority" when the agreement was ≥70%.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
delphi project
delphy study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* experts in laparoscopic cholecystectomy, with more than 10 years of experience
Exclusion Criteria
* not experts in laparoscopic cholecystectomy.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Getafe
OTHER
Complejo Hospitalario Universitario de Badajoz
OTHER
Hospital Miguel Servet
OTHER
Candido Fernando Alcazar-Lopez
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Candido Fernando Alcazar-Lopez
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alba Manuel Vázquez, Dr
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario de Getafe
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alba Manuel Vázquez
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0
Identifier Type: -
Identifier Source: org_study_id